Equitable Holdings reported July 30 results — but the earnings event that matters most arrives Monday, August 4, and the most striking development heading into it is a sharp reversal in options sentiment.
Options positioning has turned dramatically more bullish in the past week. The put/call ratio dropped to 0.92, nearly 2.3 standard deviations below its 20-day mean of 1.60 — a swing that marks call buying running well ahead of protective put demand. That is a sharp pivot from the defensive tilt that characterised positioning through most of June and July, when the PCR ran as high as 2.08. The stock itself closed at $47.65, down about 2.5% on July 31, though it has gained more than 8% over the past month — so the one-day dip looks less like a reversal and more like consolidation after a strong run.
The analyst consensus remains firmly constructive. Targets were raised across the board in early July: UBS sits at $68, Jefferies at $66, Evercore ISI at $65, with Keefe Bruyette and Mizuho both at $62. The mean target of $60.82 implies roughly 28% upside from current levels — a gap that has barely narrowed despite July's rally. Bears can point to the fact that the stock has still not closed that discount, even after a strong earnings beat in May that pushed shares up more than 5% in a single session. Barclays remains the lone note of caution with a $50 target, still Overweight but flagging valuation. Bulls counter with a trailing PE near 6x and an EPS surprise rank in the 83rd percentile, suggesting the company has a strong habit of clearing the bar.
Insider activity leans more cautious. CEO Mark Pearson sold nearly $1.9 million worth of shares on July 20 at around $48.54, following a similar $1.8 million sale in June. COO Jeffrey Hurd also sold across multiple tranches in July, totalling around $700,000. Neither sale is enormous relative to the company's size, and both carry low trade-significance scores — but the pattern of selling near current prices, rather than waiting for the Street's $60-plus targets, is a quiet counterweight to the bullish analyst narrative. On the short side, bears have largely stepped back: SI has fallen more than 44% in a month to just 1.8% of the free float, with borrow availability extremely loose and cost to borrow below 0.35%. There is no squeeze dynamic at play here.
Monday's print will test whether EQH's improving earnings trajectory — and the conviction behind six consecutive analyst target raises — can finally push the stock meaningfully toward the Street's valuation, or whether the insider selling near $48 is pricing in a ceiling the market already understands.
See the live data behind this article on ORTEX.
Open EQH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
